George Yancopoulos

George D. Yancopoulos (born 1959) is a Greek-American biomedical scientist who is the co-founder, president and chief scientific officer of Regeneron Pharmaceuticals.

Yancopoulos is a member of the National Academy of Sciences, and the holder of more than 100 patents. He is a principal inventor and developer of Regeneron's ten FDA-approved or -authorized treatments, as well as of Regeneron's foundational technologies for target and drug development, such as its proprietary TRAP technology, and the VelociGene and VelocImmune antibody technologies. Provided by Wikipedia
Showing 1 - 1 results of 1 for search 'George D. Yancopoulos', query time: 0.04s Refine Results
  1. 1
    Interleukin-19 Is a Negative Regulator of Innate Immunity and Critical for Colonic Protection

    Interleukin-19 Is a Negative Regulator of Innate Immunity and Critical for Colonic Protection by Yasu-Taka Azuma, Yukiko Matsuo, Hidemitsu Nakajima, George D. Yancopoulos, David M. Valenzuela, Andrew J. Murphy, Margaret Karow, Tadayoshi Takeuchi

    Published 2011
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: